FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/11/076385 [Registered on: 08/11/2024] Trial Registered Prospectively
Last Modified On: 28/02/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Medical Device
Physiotherapy (Not Including YOGA)
Other (Specify) [PEMF based medical device for therapeutic effect among Knee OA patients ]  
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   A clinical trial to study the effect of an appropriate pulsed electromagnetic field on knee pain, functionality, and cartilage (if any) in patients suffering from osteoarthritis 
Scientific Title of Study   To establish manufacturing lines and to perform a pivotal clinical study of a Pulsed Electromagnetic Field based biophysically stimulated orthotic system for persons with knee osteoarthritis 
Trial Acronym  NILL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Jagannatha Sahoo 
Designation  Professor and Head of Department, Physical Medicine and Rehabilitation, AIIMS Bhubaneswar 
Affiliation  All India Institute of Medical Sciences (AIIMS), Bhubaneswar 
Address  Department of Physical medicine and Rehabilitation AIIMS Bhubaneswar Khordha ORISSA India

Khordha
ORISSA
751019
India 
Phone  9437081814  
Fax    
Email  pmr_jagannath@aiimsbhubaneswar.edu.in  
 
Details of Contact Person
Scientific Query
 
Name  Pooja Kumari Jha 
Designation  Founder and CEO  
Affiliation  Swayogya Rehab Solutions Pvt Ltd 
Address  Room No. 206(C), Campus 11, School of Chemical Technology, Kalinga Institute of Industrial Technology (KIIT) -Technology Business Incubator (TBI), Bhubaneswar, Orissa

Khordha
ORISSA
751024
India 
Phone  9310207675  
Fax    
Email  swayogya19@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Pooja Kumari Jha 
Designation  Founder and CEO  
Affiliation  Swayogya Rehab Solutions Pvt Ltd 
Address  Room No. 206(C), Campus 11, School of Chemical Technology, Kalinga Institute of Industrial Technology (KIIT) -Technology Business Incubator (TBI), Bhubaneswar, Orissa

Khordha
ORISSA
751024
India 
Phone  9310207675  
Fax    
Email  swayogya19@gmail.com  
 
Source of Monetary or Material Support  
Department of Bio Technology, BIRAC, Okhla Phase III, Okhla Industrial Estate, New Delhi, Delhi 110020, India 
 
Primary Sponsor  
Name  Swayogya Rehab Solutions Pvt Ltd 
Address  Room No 206(C), Campus 11, School of Chemical Technology, Kalinga Institute of Industrial Technology (KIIT), University, KIIT-TBI, Bhubaneswar, Odisha 
Type of Sponsor  Other [Swayogya Rehab is an Indian med tech start up funded by DBT BIRAC, DTS etc ] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Jagannatha Sahoo  All India Institute of Medical Sciences (AIIMS), Bhubaneswar  Department of Physical Medicine and Rehabilitation, Near Emergency, AIIMS Bhubaneswar, Sijua, Patrapada, Bhubaneswar
Khordha
ORISSA 
9437081814

pmr_jagannath@aiimsbhubaneswar.edu.in 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 3  
Name of Committee  Approval Status 
IEC, Aatman Hospital, Bopal, Ahmedabad  Submittted/Under Review 
Institutional Ethics Committee, AIIMS Bhubaneswar  Approved 
Rajiv Gandhi Institute of Medical Sciences Srikakulam, Andhra Pradesh  Submittted/Under Review 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M170||Bilateral primary osteoarthritis of knee,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Proposed PEMF based Medical Device  Intervention: Biophysically-stimulated knee orthosis using Pulsed Electromagnetic Field (PEMF) therapy Comparator/Control: No PEMF device (standard care) The study aims to evaluate the effect of the biophysically-stimulated knee orthosis using Pulsed Electromagnetic Field (PEMF) therapy on patients with osteoarthritis (OA) by dividing participants into two groups: an experimental group and a control group. The experimental group will receive PEMF therapy with the knee orthosis for 45 minutes daily over a period of two months, while the control group will receive standard care without the PEMF device. The effects of the therapy will be assessed on the 1st, 5th, 15th, 30th, 45th, and 60th days of treatment, including an evaluation of knee sound signals (vibroarthrography) to analyze changes in joint function. 
Comparator Agent  Proposed PEMF based Medical Device  Intervention: Biophysically-stimulated knee orthosis using Pulsed Electromagnetic Field (PEMF) therapy Comparator/Control: No PEMF device (standard care) The study aims to evaluate the effect of the biophysically-stimulated knee orthosis using Pulsed Electromagnetic Field (PEMF) therapy on patients with osteoarthritis (OA) by dividing participants into two groups: an experimental group and a control group. The experimental group will receive PEMF therapy with the knee orthosis for 45 minutes daily over a period of two months, while the control group will receive standard care without the PEMF device. The effects of the therapy will be assessed on the 1st, 5th, 15th, 30th, 45th, and 60th days of treatment, including an evaluation of knee sound signals (vibroarthrography) to analyze changes in joint function. 
 
Inclusion Criteria  
Age From  40.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1) Primary OA Kellgren Lawrence Grade 1 -3 osteoarthritic patients.
2) Both male and female
3) Age 40-70 years
4) symptomatic disease for at least 6 months prior to enrolment
5) persistent pain despite receiving the maximal tolerated doses of conventional medical therapy 
 
ExclusionCriteria 
Details  1) Persons fitted with pacemaker.
2) Any prior knee surgery.
3) Persons fitted with any metallic implants.
4) Osteoarthritic patients having Kellgren Lawrence grade as 4.
5) Persons who do not provide consent for participation.
6) Presence of any medical condition that can impart effect on proposed intervention. 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Double Blind Double Dummy 
Primary Outcome  
Outcome  TimePoints 
Both pre and post data related to pain and functionality from each and individual subjects on 1st, 5th, 15th, 30th, 45th and 60th day will be recorded using following methodologies in the experimental group (i.e., various data before and after the application of proposed medical device will be monitored):
a. Pain Monitoring using Visual Analogue Scale (VAS) and Pain Pressure Threshold (PPT) device
b. Functionality Monitoring using Knee Injury and Osteoarthritis Outcome Score (KOOS) and joint Angular movement measurement using Goniometers.
c. Patient life style measurement using KOOS.
d. Effect of Proposed PEMF device (i.e.Swaknee) on Knee Sound signals (Vibroarthrography)
e. Effect of proposed device on articular (if any) using MRI 
The proposed PEMF-based medical device will be applied daily to each patient in the experimental group for 45 minutes over a period of 45 days. The effects of the therapy will be assessed on the 1st, 5th, 15th, 30th, 45th, and 60th days. After completing the two-month treatment, patients will be monitored with follow-up assessments for an additional 4 months.

Knee sound signals will also be collected to evaluate any changes in joint function related to the PEMF therapy. 
 
Secondary Outcome  
Outcome  TimePoints 
To monitor the effect on articular cartilage  6 months 
 
Target Sample Size   Total Sample Size="150"
Sample Size from India="150" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   25/11/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  


1. Title: To check the effect of Biophysically stimulated knee orthosis on pain, functionality and articular cartilage in persons with knee osteoarthritis. 


1. Background: Articular cartilage is a complex tissue that lines the joint articular surface to promote frictionless movements. It allows the joints to withstand action reaction forces generated during activities of daily living. But, when these forces fall abruptly on joint during various activities, it stimulates cartilage degeneration process. Unlike other tissues, articular cartilage is avascular in nature and lacks self -healing capability. If the cartilage degeneration process is not medically intervened at its early stages, it may lead to complete damage of the cartilage and its associated joint. Several studies have reported that the primary and secondary stages of cartilage degeneration process show symptoms of severe pain and reduced functionality of the associated joint. In many cases, the affected patients need to go for complete joint replacement surgeries at an early stage itself. This puts them under lots of burden owing to the surgery’s pain, its associated side effects, expenses and restricted functionality. If this problem remains unsolved it will further create a lot of social and financial burden to the individual and to a nation as whole. 


As far as the current treatment regimens of the cartilage degenerations are concerned, they only focus on controlling inflammations in soft tissues and its associated symptoms. None of the existing medical interventions could regenerate the cartilage. Additionally, there are no techniques available for real time monitoring of the cartilage degeneration at earlier stages. Hence, now it’s a high time to come up with a technology that can address some of the issues mentioned above. 

Biophysics is the study of biological systems and biological processes using physics-based methods or based on physical principles. In biophysical stimulation (for example using PEMF) a physical stimulus triggers a biological response by regulating specific intracellular pathways, thus acting as a drug. The device which provides this electric stimulation is known as a biophysically stimulating device. The efficacy of such an electrical stimulus, however, depends on the specific features of its physical wave, i.e. frequency and amplitude- and on the exposure time. In joint biophysics, the use of such biophysical stimulation (i.e PEMF-therapy) plays a central role since several preclinical and clinical studies have reported positive effects of PEMFs on pain, functionality, articular cartilage, subchondral bone and synovium. A biophysically stimulated PEMF device acts by producing a magnetic field that, in turn, induces currents to flow in nearby tissues. These induced currents mimic the natural electrical activities created within bones during movements, thus triggering a cascade of activities, from the cell membrane to the nucleus and on to the gene level, where specific changes take place. It is seen that the application of suitable PEMF parameters results in increased cytosolic calcium concentration and regulates the calcium-calmodulin pathway. In human chondrocytes (T/C-28a cells), PEMFs also acts by activating and upregulating the adenosine receptors, mainly the A2A and A3 subtypes, thus leading to an anti-inflammatory effect. This is an interesting biologic effect that could explicate the efficacy of PEMFs in reducing articular inflammation.

Therefore, in this proposal, we are proposing a non- invasive and an extremely portable biophysically stimulated electronic device having both therapeutic and monitoring features to slow down and to track down the cartilage health from early to advance stages. 


  1. Aims & Objective:  i. Primary: To check the effect of Biophysically stimulated orthosis on pain and functionality in persons with knee osteoarthritis.  ii. Secondary: To check the effect of Biophysically stimulated orthosis on articular cartilage in persons with knee osteoarthritis 
  2. 3. Research questions and Hypothesis: 

Research Questions: 

  1. i. Is there any significant reduction in pain after application of biophysically stimulated knee orthosis in persons with knee osteoarthritis? 
  1. ii. Is there any significant improvement in functionality after application of biophysically stimulated knee orthosis in persons with knee osteoarthritis? 
  2. iii. Is there any significant effect on the articular cartilage after application of biophysically stimulated knee orthosis in persons with knee osteoarthritis? 


Experimental Hypothesis: 

  1. i. Biophysically stimulated orthosis will reduce the pain in persons with knee osteoarthritis. 
  2. ii. Biophysically stimulated orthosis will improve the functionality in persons with knee osteoarthritis. 
  3. iii. Biophysically stimulated orthosis will impart positive effect on articular cartilage in persons with knee osteoarthritis. 


4. Materials and Methods 

i. Only humans are involved in this research, animals are not included for this study. 

ii. Randomized controlled trials will be used in the study. 


Inclusion criteria: 

  1. i. Primary OA Kellgren Lawrence Grade 1 -3 osteoarthritic patients. 
  2. ii. Both male and female 
  3. iii. Age 40-70 years 
  4. iv. symptomatic disease for at least 6 months prior to enrolment 
  5. v. persistent pain despite receiving the maximal tolerated doses of conventional medical therapy 


Exclusion criteria: 

  1. i. Persons fitted with pacemaker. 
  2. ii. Any prior knee surgery. 
  3. iii. Persons fitted with any metallic implants. 
  4. iv. Osteoarthritic patients having Kellgren Lawrence grade as 4. 
  1. v. Persons who do not provide consent for participation. 
  2. vi. Presence of any medical condition that can impart effect on proposed intervention. 


Sample Size calculations: 

Sample size in each group and sample size determination methods: Total sample size of 42 where 21 in experimental group and 21 in control group: - 

Sample size calculation is based on research entitled “Pulsed Electromagnetic fields 1h knee osteoarthritis a double blind, placebo controlled, randomized clinical trial” by Gian Luca Bagnato et.al. The pain (VAS) was taken as reference variable at end point. Assuming a pooled SD of 15.51 units, the new would require a sample size of 21 for each group. (i.e total sample size of 42 assuming each group size) to achieve a power of 80%and level of significance of 5% (two sided) for detecting a true difference in mean between the test cases and the reference group (control) of 13.6 units. 

Formula used: 

The sample size, 

N= ((Zα/2 + Zβ)2 x 2 x σ2)/ d2 ≈ 21 

Zα/2 = 1.96 (α = 0.05, confidence level) 

Zβ = 0.84 (β = 0.20, power in 80%) 

σ2 = population variance = [15.5 unit = σ] 

d = difference in mean (d = 13.6) 


5. Procedure: 

i. Subjects’ will be recruited based on inclusion and exclusion criteria. 

ii. Recruited subjects will be introduced to the study 

iii. Consent form from each and individual patient will be collected. 

iv. Randomization of the recruited subjects into control and experimental group will be done


v. Both pre and post data related to pain and functionality from each and individual subjects on 1st, 5th, 15th, 30th, 45th and 60th day will be recorded using following methodologies in the experimental group (i.e., various data before and after the application of proposed medical device will be monitored): (a). Pain Monitoring using Visual Analogue Scale (VAS) and Pain Pressure Threshold (PPT) device (b). Functionality Monitoring using Knee Injury and Osteoarthritis Outcome Score (KOOS) and joint Angular movement measurement using Goniometers. (c). Patient lifestyle measurement using KOOS. (d). Effect of proposed device on articular (if any) using MRI 


vi. The same data will also be recorded from the control group without the application of the proposed medical device. 

vii. 90 days follow-up will be taken from the recruited patients. 

viii. The third party data analysis will be done 


 
Close